With a client base that grew by over 140% in 2013 alone, the company credits the industry’s adoption of automated clinical payment processes to its platform’s unrivalled ability to significantly reduce the administrative processes, costs, and risks associated with manual processing of payments, while simultaneously increasing site satisfaction, patient retention and access to analytics and reporting.
"This milestone is a real indication of the industry’s embrace of technology to streamline clinical trial payment processes,” commented Sam Whitaker, CEO. “As one of Greenphire’s founders, I am tremendously excited and humbled to see such a positive, concrete measure of our growth and I look forward to an exciting year ahead.”
"Based on current trends, we anticipate making an additional million payments or more in 2014,” said Chief Technology Officer, David Wallace, “meaning we’ll make more payments in 2014 than we have since Greenphire’s inception! This is exciting for our business, and it proves that our infrastructure is scalable and will meet the needs of our customer base as it continues to grow exponentially.”
For further information on Greenphire and its innovative solutions please email: email@example.com or visit www.greenphire.com.
Greenphire is the industry’s leading provider of clinical payment technology, designed to change the way research professionals work. We leverage our proprietary workflow automation and advanced web‐based payment technologies to help our clients improve operational efficiency, access clinical financial analytics, reduce costs, mitigate regulatory risks, increase subject retention and compliance, and produce quantifiable results that improve clinical operations and strategic planning. Learn more at www.greenphire.com.